Capital Flow Monitor · Sponsors · CIK 2086193
Samsara Opportunity Fund, L.P.
628 MIDDLEFIELD ROAD, PALO ALTO, CA, 94301 · 650-285-4270
Pooled Investment Fund / Hedge Fund · Limited Partnership· inc. DELAWARE true 2025
Fit score
—
Offering
$200.0M
Sold
$98.0M
% sold
49.0%
Investors
19
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-09-26 | D ·current | 506(b) | $200.0M | $98.0M | 49.0% | 19 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- n/a Samsara Opportunity Fund GP, LLC — Director, Palo Alto, CA
- Srinivas Akkaraju — Director, Palo Alto, CA
-
Michael Dybbs — Director, Palo Alto, CA
3 other raises
- Abcuro, Inc. $39.4M of $176.5M · 22.3%
- Claris Biotherapeutics, Inc. $55.7M of $121.5M · 45.9%
- Delfi Diagnostics, Inc. $34.3M of $60.0M · 57.2%
-
Abraham Bassan — Director, Palo Alto, CA
1 other raise
- Rani Therapeutics Holdings, Inc. $60.3M of $60.3M · 100.0%
- Miran Ahmad — Executive Officer, Palo Alto, CA
- Abrar Hussain — Executive Officer, Palo Alto, CA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.